Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1308-1317, February 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faris, R. A.
Right arrow Articles by Hixson, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faris, R. A.
Right arrow Articles by Hixson, D. C.

Antigenic Relationship between Oval Cells and a Subpopulation of Hepatic Foci, Nodules, and Carcinomas Induced by the "Resistant Hepatocyte" Model System1

R. A. Faris2, B. A. Monfils, H. A. Dunsford and D. C. Hixson

Department of Medical Oncology, Rhode Island Hospital-Brown University, Providence, Rhode Island 02902 [R. A. F., B. A. M., D. C. H.], and Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77550 [H. A. D.]

Although proliferation of small ductular-like cells, designated oval cells, is often observed during the early stages of chemically induced hepatocarcinogenesis, their role during the carcinogenic process remains controversial. To investigate the possibility that oval cells may give rise to preneoplastic lesions that ultimately progress to hepatocellular carcinomas, we have carried out phenotypic analysis with a panel of monoclonal antibodies to determine if there is an antigenic relationship between oval cells and hepatic foci, nodules, and tumors induced by the resistant hepatocyte model system. In this model, rats are given a single dose (200 mg/kg) of diethylnitrosamine, followed by a brief exposure to 2-acetyl-aminofluorene and a partial hepatectomy. We found that approximately 10% of the early focal lesions observed 28 days after diethylnitrosamine expressed either one or both of the oval cell antigens designated OC.2 and OV-6. By 28 weeks after diethylnitrosamine, 16 of 16 hepatic nodules heterogeneously expressed OV-6 whereas 5–10% of the persistent nodules contained scattered small hepatocyte-like cells that expressed OC.2. Examination of resistant hepatocyte-induced primary hepatocellular carcinomas with an expanded panel of monoclonal antibodies demonstrated that most cells comprising 29 of 29 tumors expressed OV-6 and that 15–20% of the OV-6-positive tumors contained subpopulations of cells also expressing 3 additional oval cell antigens, OC.2, OC.3, and OV-1. All of the tumors examined expressed normal levels of the hepatocyte antigens, H.1 and HBD.1, and had dramatically reduced levels of H.2, H.4, and cell CAM 105 but showed elevated levels of the transferrin receptor, {gamma}-glutamyltranspeptidase, and the normal hepatocyte antigen, H.5. In conclusion, our findings demonstrate an antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and tumors in the resistant hepatocyte model, suggesting that at least some primary tumors may be derived from oval cells in this model system.

1 This investigation was supported by Research Grants CA 42716 and CA 34635 from NIH, by Grant 84 A02 from the American Institute for Cancer Research, and by a grant from Innovative Research of America, Rockville, MD.

2 To whom requests for reprints should be addressed, at the Department of Medical Oncology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02902.

Received 3/15/90. Accepted 12/ 4/90.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
E. R. Lemmer, C. J. Vessey, W. C. A. Gelderblom, E. G. Shephard, D. J. Van Schalkwyk, R. A. Van Wijk, W. F. O. Marasas, R. E. Kirsch, and P. d. l. M. Hall
Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study
Carcinogenesis, July 1, 2004; 25(7): 1257 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Holic, T. Suzuki, A. Corlu, D. Couchie, M. N. Chobert, C. Guguen-Guillouzo, and Y. Laperche
Differential Expression of the Rat {gamma}-Glutamyl Transpeptidase Gene Promoters along with Differentiation of Hepatoblasts into Biliary or Hepatocytic Lineage
Am. J. Pathol., August 1, 2000; 157(2): 537 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Kano, M. Noguchi, M. Kodama, and T. Tokiwa
The in Vitro Differentiating Capacity of Nonparenchymal Epithelial Cells Derived from Adult Porcine Livers
Am. J. Pathol., June 1, 2000; 156(6): 2033 - 2043.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
P. M. Novikoff and A. Yam
Stem Cells and Rat Liver Carcinogenesis: Contributions of Confocal and Electron Microscopy
J. Histochem. Cytochem., May 1, 1998; 46(5): 613 - 626.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R.-K. He and M. Gascon-Barré
Influence of the Vitamin D Status on the Early Hepatic Response to Carcinogen Exposure in Rats
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 464 - 469.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
M. Neveu, J. Hully, K. Babcock, E. Hertzberg, B. Nicholson, D. Paul, and H. Pitot
Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver
J. Cell Sci., January 1, 1994; 107(1): 83 - 95.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.